Econazole Induces p53-Dependent Apoptosis and Decreases Metastasis Ability in Gastric Cancer Cells |
Choi, Eun Kyoung
(Rare Disease Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB))
Park, Eun Jung (Rare Disease Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB)) Phan, Tien Thuy (Rare Disease Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB)) Kim, Hea Dong (Rare Disease Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB)) Hoe, Kwang-Lae (Department of New Drug Development, Chungnam National University) Kim, Dong-Uk (Rare Disease Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB)) |
1 | Huang, J. K., Liu, C. S., Chou, C. T., Liu, S. I., Hsu, S. S., Chang, H. T., Hsieh, C. H., Chang, C. H., Chen, W. C. and Jan, C. R. (2005) Effects of econazole on Ca2+ levels in and the growth of human prostate cancer PC3 cells. Clin. Exp. Pharmacol. Physiol. 32, 735-741. DOI |
2 | Imazeki, F., Omata, M., Nose, H., Ohto, M. and Isono, K. (1992) p53 gene mutations in gastric and esophageal cancers. Gastroenterology 103, 892-896. DOI |
3 | Jackson, C. J., Lamb, D. C., Kelly, D. E. and Kelly, S. L. (2000) Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis. FEMS Microbiol. Lett. 192, 159-162. DOI |
4 | Jung, K. W., Won, Y. J., Kong, H. J. and Lee, E. S. (2018) Prediction of Cancer Incidence and Mortality in Korea, 2018. Cancer Res. Treat. 50, 317-323. DOI |
5 | Li, H. C., Cao, D. C., Liu, Y., Hou, Y. F., Wu, J., Lu, J. S., Di, G. H., Liu, G., Li, F. M., Ou, Z. L., Jie, C., Shen, Z. Z. and Shao, Z. M. (2004) Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res. Treat. 88, 75-85. DOI |
6 | Najid, A. and Ratinaud, M. H. (1991) Comparative studies of steroidogenesis inhibitors (econazole, ketoconazole) on human breast cancer MCF-7 cell proliferation by growth experiments, thymidine incorporation and flow cytometric DNA analysis. Tumori 77, 385-390. DOI |
7 | Nardone, P. A., Slotman, G. J. and Vezeridis, M. P. (1988) Ketoconazole: a thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanoma. J. Surg. Res. 44, 425-429. DOI |
8 | Osser, S., Haglund, A. and Westrom, L. (1991) Treatment of candidal vaginitis. A prospective randomized investigator-blind multicenter study comparing topically applied econazole with oral fluconazole. Acta Obstet. Gynecol. Scand. 70, 73-78. DOI |
9 | Trachtenberg, J. and Pont, A. (1984) Ketoconazole therapy for advanced prostate cancer. Lancet 2, 433-435. DOI |
10 | Tolbert, D., Fenoglio-Preiser, C., Noffsinger, A., De Voe, G., MacDonald, J., Benedetti, J. and Stemmermann, G. (1999) The relation of p53 gene mutations to gastric cancer subsite and phenotype. Cancer Causes Control 10, 227-231. DOI |
11 | Tzanakakis, G. N., Agarwal, K. C. and Vezeridis, M. P. (1990) Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole. Cancer 65, 446-451. DOI |
12 | Vogelstein, B., Lane, D. and Levine A. J. (2000) Surfing the p53 network. Nature 408, 307-310. DOI |
13 | Strushkevich, N., Usanov, S. A. and Park, H. W. (2010) Structural basis of human CYP51 inhibition by antifungal azoles. J. Mol. Biol. 397, 1067-1078. DOI |
14 | Prajna, N. V., John, R. K., Nirmalan, P. K., Lalitha, P. and Srinivasan, M. (2003) A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br. J. Ophthalmol. 87, 1235-1237. DOI |
15 | Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S. and Saghafinia, S., Chakravarty, D., Daian, F., Gao, Q., Bailey, M. H., Liang, W. W., Foltz, S. M., Shmulevich, I., Ding, L., Heins, Z., Ochoa, A., Gross, B., Gao, J., Zhang, H., Kundra, R., Kandoth, C., Bahceci, I., Dervishi, L., Dogrusoz, U., Zhou, W., Shen, H., Laird, P. W., Way, G. P., Greene, C. S., Liang, H., Xiao, Y., Wang, C., Iavarone, A., Berger, A. H., Bivona, T. G., Lazar, A. J., Hammer, G. D., Giordano, T., Kwong, L. N., McArthur, G., Huang, C., Tward, A. D., Frederick, M. J., McCormick, F., Meyerson, M. Cancer Genome Atlas Research Network, Van Allen, E. M., Cherniack, A. D., Ciriello, G., Sander, C. and Schultz, N. (2018) Oncogenic signaling pathways in the cancer genome atlas. Cell 173, 321-337.e10. DOI |
16 | Shiao, Y. H., Palli, D., Caporaso, N. E., Alvord, W. G., Amorosi, A., Nesi, G., Saieva, C., Masala, G., Fraumeni, J. F. and Rice, J. M. (2000) Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers. Cancer Epidemiol. Biomarkers Prev. 9, 631-633. |
17 | Bellini, M. F., Cadamuro, A. C. T., Succi, M., Proença, M. A. and Silva, A. E. (2012) Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J. Biomed. Biotechnol. 2012, 891961. |
18 | Sun, J., Yu, C. H., Zhao, X. L., Wang, Y., Jiang, S. G. and Gong, X. F. (2014) Econazole nitrate induces apoptosis in MCF-7 cells via mitochondrial and caspase pathways. Iran. J. Pharm. Res. 13, 1327-1334. |
19 | Takashima, A., Yamada, Y., Nakajima, T. E., Kato, K., Hamaguchi, T. and Shimada, Y. (2009) Standard first-line chemotherapy for metastatic gastric cancer in Japan has met the global standard: evidence from recent phase III trials. Gastrointest. Cancer Res. 3, 239-244. |
20 | Warrilow, A. G., Martel, C. M., Parker, J. E., Melo, N., Lamb, D. C., Nes, W. D., Kelly, D. E. and Kelly, S. L. (2010) Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51). Antimicrob. Agents Chemother. 54, 4235-4245. DOI |
21 | Bogle, R. G. and Vallance, P. (1996) Functional effects of econazole on inducible nitric oxide synthase: production of a calmodulin-dependent enzyme. Br. J. Pharmacol. 117, 1053-1058. DOI |
22 | Aron-Brunetiere, R., Dompmartin-Pernot, D. and Drouhet, E. (1977) Treatment of pityriasis capitis (dandruff) with econazole nitrate. Acta Derm. Venereol. 57, 77-80. |
23 | Bae, S. H., Park, J. H., Choi, H. G., Kim, H. and Kim, S. H. (2018) Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast cancer cells. Biomol. Ther. (Seoul) 26, 494-502. DOI |
24 | Blagosklonny, M. V., Dixon, S. C. and Figg, W. D. (2000) Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines. J. Urol. 163, 1022-1026. DOI |
25 | Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. and Jemal, A. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394-424. DOI |
26 | Busuttil, R. A., Zapparoli, G. V., Haupt, S., Fennell, C., Wong, S. Q., Pang, J. M., Takeno, E. A., Mitchell, C., Di Costanzo, N., Fox, S., Haupt, Y., Dobrovic, A. and Boussioutas, A. (2014) Role of p53 in the progression of gastric cancer. Oncotarget 5, 12016-12026. DOI |
27 | Denyer, M. D., Hubbard, R. and Marks, V. (1985) The effects of econazole on the growth of murine myeloma cells and its use in hybridoma production. Dev. Biol. Stand. 60, 503-508. |
28 | Talvensaari-Mattila, A., Paakko, P., Hoyhtya, M., Blanco-Sequeiros, G. and Turpeenniemi-Hujanen, T. (1998) Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma. Cancer 83, 1153-1162. DOI |
29 | Yan, Z., Liu, X., Liu, Y., Han, Y., Lin, M., Wang, W., Guan, X., Zhu, S., Zhang, H., Wang, Q., Chou, L., Zhu, X. and Hua, H. (2016) The efficacy and safety of miconazole nitrate mucoadhesive tablets versus itraconazole capsules in the treatment of oral candidiasis: an open-label, randomized, multicenter trial. PLoS ONE 11, e0167880. DOI |
30 | Cogswell, S., Berger, S., Waterhouse, D., Bally, M. B. and Wasan, E. K. (2006) A parenteral econazole formulation using a novel micelleto-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model. Pharm. Res. 23, 2575-2585. DOI |
31 | Dong, C., Yang, R., Li, H., Ke, K., Luo, C., Yang, F., Shi, X. N., Zhu, Y., Liu, X., Wong, M. H., Lin, G., Wang, X., Leung, K. S., Kung, H. F., Chen, C. and Lin, M. C. (2017) Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells. Sci. Rep. 7, 17987. DOI |
32 | Gabbert, H. E., Müller, W., Schneiders, A., Meier, S. and Hommel, G. (1995) The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 76, 720-726. DOI |
33 | Gialeli, C., Theocharis, A. D. and Karamanos, N. K. (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278, 16-27. DOI |
34 | Gleeson, C., Sloan, J., McManus, D., Maxwell, P., Arthur, K., Mc-Guigan, J., Ritchie, A. and Russell, S. (1998) Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br. J. Cancer 77, 277-286. DOI |
35 | Hantschke, D., Schulte, R., Dabag, S. and Greschuna, D. (1978) Treatment with econazole of a case of pulmonary aspergillosis. Mykosen Suppl. 1, 230-235. |
36 | Ho, Y. S., Wu, C. H., Chou, H. M., Wang, Y. J., Tseng, H., Chen, C. H., Chen, L. C., Lee, C. H. and Lin, S. Y. (2005) Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways. Food Chem. Toxicol. 43, 1483-1495. DOI |